鄰近類別 會議論文/會議摘要 [41/48] 報告 [0/1] 專利 [0/11] 類別統計 近3年內發表的文件:0(0.00%) 含全文筆數:193(99.48%) 文件下載次數統計 下載大於0次:193(100.00%) 下載大於100次:193(100.00%) 檔案下載總次數:122368(83.64%) 最後更新時間: 2024-11-28 13:17 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Identification of prognostic biomar... A novel NRF2/ARE inhibitor gossypol... Targeting lysosomal cysteine protea... c-MYC-directed NRF2 drives malignan... Ephrin A4-ephrin receptor A10 signa... Phase I dose-escalation study of SC... Germline susceptibility variants im... Index of cancer-associated fibrobla... The SMAC mimetic LCL161 is a direct... The tumor suppressor TGFBR3 blocks ...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目126-150 / 194. (共8頁) << < 1 2 3 4 5 6 7 8 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2010-08	Synthesis and biological evaluation of 7-arylindoline-1-benzenesulfonamides as a novel class of potent anticancer agents	MedChemComm. 2010 Aug;1(2):152-155.
2010-06-18	Cytotoxic C35 terpenoid cryptotrione from the bark of cryptomeria japonica	Organic Letters. 2010 Jun;12(12):2786-2789.
2010-06	Design and synthesis of alpha-ketoamides as cathepsin S inhibitors with potential applications against tumor invasion and angiogenesis	Journal of Medicinal Chemistry. 2010 Jun;53(11):4545-4549.
2010-05	Chamaecypanone C, a novel skeleton microtubule inhibitor, with anticancer activity by trigger caspase 8-Fas/FasL dependent apoptotic pathway in human cancer cells	Biochemical Pharmacology. 2010 May;79(9):1261-1271.
2010-05	Recent advances in anti-survivin treatments for cancer	Current Medicinal Chemistry. 2010 May;17(15):1509-1515.
2010-04-15	Targeting Hsp90 with small molecule inhibitors induces the over-expression of the anti-apoptotic molecule, survivin, in human A549, HONE-1 and HT-29 cancer cells	Molecular Cancer. 2010 Apr 15;9:Article number 77.
2010-04	Arecoline arrests cells at prometaphase by deregulating mitotic spindle assembly and spindle assembly checkpoint: Implication for carcinogenesis	Oral Oncology. 2010 Apr;46(4):255-262.
2010-03-11	5-Amino-2-Aroylquinolines as Highly Potent Tubulin Polymerization Inhibitors	Journal of Medicinal Chemistry. 2010 Mar 11;53(5):2309-2313.
2010-03	Paclitaxel and carboplatin-induced complete remission in peritoneal carcinomatosis of unknown origin: A report of two cases and review of the literature	Tumori. 2010 Mar-Apr;96(2):336-339.
2010-02	Antitumor activities and pharmacokinetics of silatecans DB-67 and DB-91	Pharmacological Research. 2010 Feb;61(2):108-115.
2009-12	Alpha-fetoprotein response in advanced hepatocellular carcinoma receiving cytostatic agent	Journal of Clinical Oncology. 2009 Dec;27(36):e271.
2009-08-13	Synthesis and evaluation of 3-aroylindoles as anticancer agents: Metabolite approach	Journal of Medicinal Chemistry. 2009 Aug 13;52(15):4941-4945.
2009-07-23	Generation of ligand-based pharmacophore model and virtual screening for identification of novel tubulin inhibitors with potent anticancer activity	Journal of Medicinal Chemistry. 2009 Jul 23;52(14):4221-4233.
2009-07-03	Survivin counteracts the therapeutic effect of microtubule de-stabilizers by stabilizing tubulin polymers	Molecular Cancer. 2009 Jul 3;8:Article number 43.
2009-04-17	Synthesis and structure-activity relationships of 1-benzyl-4,5,6-trimethoxyindoles as a novel class of potent antimitotic agents	ChemMedChem. 2009 Apr 17;4(4):588-593.
2009-04	Aurora kinase inhibitors in preclinical and clinical testing	Expert Opinion on Investigational Drugs. 2009 Apr;18(4):379-398.
2009-04	Increasing incidence of intrahepatic cholangiocarcinoma and its relationship to chronic viral hepatitis	Journal of the National Comprehensive Cancer Network. 2009 Apr;7(4):423-427.
2009-03	Advances in Aurora kinase inhibitor patents	Expert Opinion on Therapeutic Patents. 2009 Mar;19(3):321-356.
2008-12-25	Synthesis and structure-activity relationships of 2-amino-1-aroylnaphthalene and 2-hydroxy-1-aroylnaphthalenes as potent antitubulin agents	Journal of Medicinal Chemistry. 2008 Dec 25;51(24):8163-8167.
2008-10-28	Human DNA polymerase eta activity and translocation is regulated by phosphorylation	Proceedings of the National Academy of Sciences of the United States of America. 2008 Oct 28;105(43):16578-16583.
2008-10	Modern staging and utility of PET imaging in esophageal cancer management	Journal of the National Comprehensive Cancer Network. 2008 Oct;6(9):862-869.
2008-08	Transcriptional repression of O-6-methylguanine DNA methyltransferase gene rendering cells hypersensitive to N,N '-bis(2-chloroethyl)-N-nitrosurea in camptothecin-resistant cells	Molecular Pharmacology. 2008 Aug;74(2):517-526.
2008-07-24	Discovery of 4-amino and 4-hydroxy-1-aroylindoles as potent tubulin polymerization inhibitors	Journal of Medicinal Chemistry. 2008 Jul;51(14):4351-4355.
2008-02	A novel peroxisome proliferator-activated receptor alpha/gamma agonist, BPR1H0101, inhibits topoisomerase II catalytic activity in human cancer cells	Anti-Cancer Drugs. 2008 Feb;19(2):151-158.
2007-11-15	Tamoxifen accelerates proteasomal degradation of O-6-methylguanine DNA methyltransferase in human cancer cells	International Journal of Cancer. 2007 Nov;121(10):2293-2300.

顯示項目126-150 / 194. (共8頁) << < 1 2 3 4 5 6 7 8 > >> 每頁顯示[10|25|50]項目